Inventor · disambiguated record
John Arthur
Also filed as: ARTHUR JOHN · ARTHUR JOHN CHARLES
10 granted patents·9 pending applications·84 citations·filing 2001–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0196US10166183B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Jan 1, 2019·22 cites·21 claims
- 0294US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0394US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0490US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 0590US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 0689US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0782US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 0882US2023355514A1Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0981US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 1077US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1176US10966922B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·16 claims
- 1274US2021205214A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1373US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 1473US2021322308A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1572US2019133935A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1669US2019083484A1Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1763US2017087147A1Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1847US6632938B2Processes of purifying oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 14, 2003·0 cites·61 claims
- 1933US2019076466A1Reduced sodium poloxamer-188 formulations and methods for useMAST THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →